Schuitemaker H - Search Results

1

Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study.

Reijers MH, Weverling GJ, Jurriaans S, Wit FW, Weigel HM, Ten Kate RW, Mulder JW, Frissen PH, van Leeuwen R, Reiss P, Schuitemaker H, de Wolf F, Lange JM. Reijers MH, et al. Among authors: schuitemaker h. Lancet. 1998 Jul 18;352(9123):185-90. doi: 10.1016/s0140-6736(98)06193-5. Lancet. 1998. PMID: 9683207 Clinical Trial.

2

CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients.

Wit FW, van Rij RP, Weverling GJ, Lange JM, Schuitemaker H. Wit FW, et al. Among authors: schuitemaker h. J Infect Dis. 2002 Dec 15;186(12):1726-32. doi: 10.1086/345677. Epub 2002 Nov 22. J Infect Dis. 2002. PMID: 12447757

3

Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients.

Sankatsing SU, Jurriaans S, van Swieten P, van Leth F, Cornelissen M, Miedema F, Lange JM, Schuitemaker H, Prins JM. Sankatsing SU, et al. Among authors: schuitemaker h. AIDS. 2004 Sep 24;18(14):1925-31. doi: 10.1097/00002030-200409240-00008. AIDS. 2004. PMID: 15353978 Clinical Trial.

4

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy.

Hoetelmans RM, Reijers MH, Weverling GJ, ten Kate RW, Wit FW, Mulder JW, Weigel HM, Frissen PH, Roos M, Jurriaans S, Schuitemaker H, de Wolf F, Beijnen JH, Lange JM. Hoetelmans RM, et al. Among authors: schuitemaker h. AIDS. 1998 Jul 30;12(11):F111-5. doi: 10.1097/00002030-199811000-00002. AIDS. 1998. PMID: 9708400 Clinical Trial.

5

Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy.

Weverling GJ, Lange JM, Jurriaans S, Prins JM, Lukashov VV, Notermans DW, Roos M, Schuitemaker H, Hoetelmans RM, Danner SA, Goudsmit J, de Wolf F. Weverling GJ, et al. Among authors: schuitemaker h. AIDS. 1998 Jul 30;12(11):F117-22. doi: 10.1097/00002030-199811000-00003. AIDS. 1998. PMID: 9708401

6

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.

Prins JM, Jurriaans S, van Praag RM, Blaak H, van Rij R, Schellekens PT, ten Berge IJ, Yong SL, Fox CH, Roos MT, de Wolf F, Goudsmit J, Schuitemaker H, Lange JM. Prins JM, et al. Among authors: schuitemaker h. AIDS. 1999 Dec 3;13(17):2405-10. doi: 10.1097/00002030-199912030-00012. AIDS. 1999. PMID: 10597782

7

Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study.

Reijers MH, Weigel HM, Hart AA, Ten Kate RW, Mulder JW, Reiss P, Schuitemaker H, Hoetelmans RM, Weverling GJ, Lange JM. Reijers MH, et al. Among authors: schuitemaker h. AIDS. 2000 Jan 7;14(1):59-67. doi: 10.1097/00002030-200001070-00007. AIDS. 2000. PMID: 10714568 Clinical Trial.

8

Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection.

Putter H, Prins JM, Jurriaans S, Roos M, Ferguson NM, van Praag R, van der Hoek L, Schuitemaker H, Anderson RM, Goudsmit J, Lange JM, de Wolf F. Putter H, et al. Among authors: schuitemaker h. AIDS. 2000 Dec 22;14(18):2831-9. doi: 10.1097/00002030-200012220-00004. AIDS. 2000. PMID: 11153664

9

The ADAM study continued: maintenance therapy after 50 weeks of induction therapy.

Reijers MH, Weverling GJ, Jurriaans S, Roos MT, Wit FW, Weigel HM, Ten Kate RW, Mulder JW, Richter C, Ter Hofstede HJ, Sprenger H, Hoetelmans RM, Schuitemaker H, Lange JM. Reijers MH, et al. Among authors: schuitemaker h. AIDS. 2001 Jan 5;15(1):129-31. doi: 10.1097/00002030-200101050-00022. AIDS. 2001. PMID: 11192858 Clinical Trial. No abstract available.

10

Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemia.

Goudsmit J, Bogaards JA, Jurriaans S, Schuitemaker H, Lange JM, Coutinho RA, Weverling GJ. Goudsmit J, et al. Among authors: schuitemaker h. AIDS. 2002 Mar 29;16(5):791-3. doi: 10.1097/00002030-200203290-00016. AIDS. 2002. PMID: 11964537 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

352 results

Search Page